Client profile
Helix Pharma, a Swiss mid-size pharmaceutical company with 800 staff.
Challenge and scope
Coding and completeness checks precede safety review. Accuracy using the Medical Dictionary for Regulatory Activities (MedDRA) is 94.2% in the quality sample.
SAE reports can arrive through different channels with partial information, duplicate references, or a translation still pending. A safety reviewer needs to see what was received, how it was coded, and which details require further information. An incomplete handoff can consume time close to a client-managed deadline.
Delivery workflow
Process 1,800 monthly SAE cases across 14 therapeutic areas and six languages. Validate completeness, apply the client’s coding conventions, and route the prepared cases for safety review.
Log the incoming report and source documents in the authorized safety system with the client’s timing conventions. Check required fields, look for a prior case reference, and apply the client’s MedDRA coding conventions. Record missing information and prepare a case summary for the safety reviewer with the relevant evidence attached.
Sample cases for coding agreement and completeness, with a focus on complex narratives and translated reports. Record coding disagreements and update adjudicated examples under the client’s procedure. Track when the case is ready for review and which outstanding item or approval can affect the next handoff.
Delivery team
Poland, about 13 FTE. 1 PV lead, 3 safety reviewers and 9 case processing associates.
Systems and tools
Argus, MedDRA, client safety database.
Client decision rights
The pharmaceutical company owns causality assessment, signal detection, and submission sign-off.
Early milestone
In week 5, SAE case processing reaches nine hours.
Outcomes
Company-reported results, with the baseline, measurement window and supporting record described for each measure.
| Measure | Baseline | Result | Window | Supporting record |
|---|---|---|---|---|
| SAE processing time | 22 hours | 3 hours | 6 months | Argus case report |
| MedDRA coding accuracy | 94.2% | 99.96% | 6 months | Double-coded QA sample |
| Case completeness at first review | 68% | 96% | 6 months | QA review sample |
| Regulatory submission timeliness | 91% | 100% | 6 months | Safety database report |
Interpreting the results
The case records a reduction from 22 to three hours of case processing with better first-review completeness. Record receipt, preparation, safety sign-off, and submission dates separately. Interpret the reported precision of 99.96% MedDRA coding accuracy with the reviewed sample size and definition of an error.
Recommendations for new clients
For pharmacovigilance teams with high case volumes, define the processing timestamp and sample double-coded cases. Record internal handoff time and submission timeliness separately.
Start with recent case examples that include a duplicate, missing information, and a translation. Provide the client’s safety procedure, coding conventions, applicable clock definitions, and named decision owners. Review the first prepared cases with the safety team and trace each data field and coding change to its source.